Scientific conference spotlights PYC's work on blindness disease treatment
PYC Therapeutics Ltd will have data from its ongoing trial into a drug candidate to treat Retinitis Pigmentosa type 11 presented in Singapore
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
ADL | offer from 50c a share to at least 60c a share | 19/08/11 | 1 | 1.2K | |||
|
|||||||
ADL | more "buy" recommendations | 20/12/10 | 0 | 685 | |||
|
|||||||
ADL | Ann: Initial Director's Interest Notice | 05/11/10 | 0 | 346 | |||
|
|||||||
ADL | Ann: Initial Director's Interest Notice | 01/11/10 | 0 | 314 | |||
|
|||||||
ADL | Ann: Final Director's Interest Notice | 01/11/10 | 0 | 324 | |||
|
|||||||
ADL | Ann: Final Director's Interest Notice | 01/11/10 | 0 | 357 | |||
|
|||||||
ADL | Ann: Revised Master Timetable for transactions | 01/11/10 | 0 | 310 | |||
|
|||||||
ADL | Ann: Reduction of Capital Meeting Results | 29/10/10 | 0 | 231 | |||
|
See All Discussions